Intravenous S-ketamine's analgesic efficacy in third molar surgery. A randomized placebo-controlled double-blind clinical trial.
Lars B ErikssonTorsten GordhRolf KarlstenRiccardo LoMartireAndreas ThorÅke TegelbergPublished in: British journal of pain (2023)
Pre-emptive S-ketamine 0.25 mg/kg gave a global significant reduction of pain by VAS during the first 24 h postoperatively. The time from end of surgery to first rescue medication were longer in the high-dose ketamine group compared to both low-dose ketamine and placebo groups.
Keyphrases
- double blind
- high dose
- placebo controlled
- pain management
- low dose
- clinical trial
- minimally invasive
- phase iii
- coronary artery bypass
- phase ii
- study protocol
- stem cell transplantation
- neuropathic pain
- chronic pain
- healthcare
- open label
- squamous cell carcinoma
- radiation therapy
- acute coronary syndrome
- emergency department
- spinal cord injury
- atrial fibrillation
- postoperative pain
- electronic health record